ALCON Overview
Company Headquarters: Geneva, Switzerland
Founded: 1945
Workforce: ~475,000
Company Working: Alcon develops supplements, contact lenses and solutions, eye drops, and other products for surgical and vision care areas, such as cataracts, glaucoma, retinal diseases, and refractive errors. The company has a presence in over 70 countries and serves patients in more than 140 countries. It invests a substantial amount of funds in research and development to meet customers’ needs and patients’ demands. Also, it has active collaborations with various service providers. For instance, the company has a partnership with SightLife, the Eye Donation Counselor program established in hospitals in India, which is enabling cornea transplant surgeries that might not have been possible otherwise. Alcon comprises of a strong pipeline for the future, constituting non-Rx dry eye drops, contact lens care solutions, ocular vitamins, non-Rx allergy drops, and non-Rx red-eye drops in the area of ocular health.
Strategy
Alcon uses science-based innovation to deliver better patient outcomes to become a leader in growing areas of healthcare. The company seeks to develop products that can produce positive outcomes for patients and healthcare providers. By collaborating with healthcare providers and nutritional companies, it intends to develop products to amplify its target audience. For instance, in November 2019, Alcon Retina Fellows Institute conducted a workshop focused on gaining hands-on surgical training and mentorship from leading ophthalmologists. Meanwhile, it believes in expanding its presence in emerging markets of Asia, Africa, and Latin America, where there is a fast-growing demand for access to high- quality medicines and healthcare.
